Harvard Pulmonary And Critical Care Medicine 2026

• Target Audience: pulmonologists, intensivists, and critical care physicians, internists, hospital medicine physicians
• Sample video: contact me for sample video
• Information:

1. Overview

Pulmonary and Critical Care Medicine 2026 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for patients with common, rare, and challenging pulmonary conditions and for patients requiring critical care.

Pulmonary and Critical Care Medicine is a live online course, using live streaming, electronic Q&A, and other remote learning technologies.

This comprehensive course provides education and updates to optimize your care of patients with pulmonary conditions and patients requiring critical care. Physicians, NPs, and PAs can rely on this program to enhance their practice and advance their knowledge with evidence-based strategies for evaluation, diagnosis, treatment, and procedures.

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways and provide specific recommendations to incorporate the latest updates into your practice. This year’s program covers:

New in 2026: breaking news updates in pulmonary and critical care medicine

The most current guidelines for treating sepsis

Evidence-based treatment of ARDS

Interventional pulmonology: diagnostic procedures, therapeutic interventions, and as an alternative to surgery

High-flow oxygen therapy for respiratory failure

Updates on biologics in asthma and other lung disease

Diagnosis and management of bleeding diatheses in the ICU

New concepts in the use of vasopressors in septic shock

New drugs and combinations in pulmonary hypertension

New evidence on sedation, analgesia, and early mobility in the ICU

Point-of-care pulmonary ultrasound in the intensive care unit

Lung microbiome: emerging implications for lung health

Emerging evidence for targeted temperature management

Steroid-sparing agents for interstitial lung disease

Pulmonary embolus: the latest treatment strategies

Guidance to conduct end-of-life discussions

Updates in pulmonary pathology

New treatment options in cystic fibrosis

Handling neurologic and surgical emergencies in the medical ICU

A Practical, Comprehensive Update for Busy Clinicians

This program delivers comprehensive updates to improve evaluation, diagnosis, and management of the broad array of pulmonary and critical care conditions:

IPF

Non-IPF ILD

ARDS

Sarcoidosis

Lung transplantation

Bronchiectasis

Cystic fibrosis

Lung nodules

Lung cancer

Sepsis

Pleural disease

Pneumonia

Tuberculosis

Thromboembolism

COPD

Asthma

GERD

Neurologic issues in the ICU

Sleep-disordered breathing

Surgical emergencies

Acute pancreatitis

Atypical mycobacterial disease

Pulmonary hypertension

Post-cardiac arrest care

Hypersensitivity pneumonitis

Ventilator management

Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care.

2. Learning Objectives

Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features

Apply evidence from recent literature to clinical case management

Apply new clinical practice guidelines to improve patient outcomes

Utilize diagnostic and therapeutic tools offered by specialists outside of pulmonary and critical care medicine to optimally care for complicated patients

3. Target Audience

Best for pulmonologists, intensivists, and critical care nurses who want updates on respiratory diseases, ICU management, and sleep medicine.

Who Should Participate

Physicians, Nurse Practitioners, and Physician Assistants in the fields of:

Pulmonology

Critical Care

Internal Medicine

Hospital Medicine

… and other medical professionals who want to advance their knowledge of pulmonary and critical care medicine

4. Topics

01 Breaking News in Pulmonary Medicine Dr. Benjamin Medof

02 Cystic Fibrosis Understanding CFTR and New Treatment Dr. Isabel Neuringer

03 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis Dr. Christopher Richards

04 Lung Transplantation 2026 Referral Patient Selection, Lung Allocation, and COVID Dr. Brian Keller

05 Exercise and Cardiopulmonary Disorders Indications and Interpretation Dr. C. Corey Hardin

06 Q&A with Speakers Drs. Isabel Neuringer, Christopher Richards, Brian Keller, and C. Corey Hardin

07 Pulmonary Pathology Interstitial Lung Disease Dr. Lida Hariri

08 Looking Deeper Patterns and Insights from Chest Radiology Dr. Amita Sharma

09 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD Dr. Barry Shea

10 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My! Dr. Sydney Montesi

11 Treatment Challenges of Pulmonary Sarcoidosis Dr. Robert Hallowell

12 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs Dr. Grace Peloquin

13 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Barry Shea, Robert Hallowell, Grace Peloquin, and Sydney Montesi

14 Sedation, Analgesia, and Early Mobility The State ofthe Artin 2026 Dr. Crystal North

15 Noninvasive Respiratory Supportfor Acute Respiratory Failure Less May NOT Be Best Carolyn La Vita, MHA, RRT

16 Novel Ventilator Modes The Hype and Reality Carolyn La Vita, MHA, RRT

17 ARDS State-of-the-Art Strategies to Protectthe Lung Dr. Jehan Alladina

18 After the ICU Post-ICU Care Syndrome and Recovery Dr. George Alba

19 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Crystal North, George Alba, and Jehan Alladina, and Carolyn La Vita, MHA, RRT

20 From Ancient Egyptto Balanced Crystalloids Medicine’s Attempts to Manage Sepsis Dr. Eric Schmidt

21 Fluid Responsiveness Dr. David Ziehr

22 Vasopressors in Septic Shock Old Friends and New Dr. Jason Griffith

23 Approach to Empiric Antibiotics in the ICU Dr. Alyssa Letourneau

24 Approach to the Immunocompromised Critically Ill Patient Dr. Lisa Bebell

25 Renal Replacement Therapy in the ICU What and When to Start(or Not) Dr. Andrew Allegretti

26 Q&A with Speakers Drs. Kathryn Hibbert, Lisa Bebell, Alyssa Letourneau, David Ziehr, Eric Schmidt, Jason Griffith, and Andrew Allegretti

27 Common Neurologic Issues in the ICU Dr. Sahar Zafar

28 TTM and Neuro-prognostication After Cardiac Arrest Dr. David Greer

29 Surgical Emergencies in the Medical ICU Dr. Noelle Saillant

30 Updates in Management of Acute Pancreatitis Dr. Casey Luckhurst

31 Advanced Cardiac Supportin the ICU Dr. David Dudzinski

32 Q&A with Speakers Drs. Sahar Zafar, David Greer, Noelle Saillant, David Dudzinski, and Casey Luckhurst

33 Breaking Updates in Critical Care Dr. Kathryn Hibbert

34 Management ofthe Acutely Hemorrhaging Patient Dr. Raghu Chivkula

35 Point-of-Care Ultrasound in the Intensive Care Unit Dr. Jonah Rubin

36 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care Dr. Joshua Metlay

37 Prognosis and Uncertainty in the ICU Dr. Emily Rubin

38 Palliative Care in Advanced Lung Disease Dr. Jaclyn Shameklis

39 Q&A with Speakers Drs. Kathryn Hibbert, Emily Rubin, Joshua Metlay, Jaclyn Shameklis, and Jonah Rubin

40 Pleural Disease 2026 Updates Dr. Fayez Kheir

41 Interventional Pulmonology in 2026 Dr. Colleen Keyes

42 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond Dr. Colleen Keyes

43 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies Dr. Allison Chang

44 COPD 2026 Dr. Walter O’Donnell

45 Q&A with Speakers Drs. Angela Frank, Fayez Kheir, Colleen Keyes, and Walter O’Donnell

46 Aspergillus Lung Disease Dr. Rod Rahimi

47 Asthma What’s New in 2026 Dr. Miranda Theodore

48 New Therapeutics in Lung Disease The Age of Immunotherapy Dr. Benjamin Medof

49 A Strategic Approach to the Management of Pulmonary Nodules Dr. Angela Frank

50 Tuberculosis in 2026 Dr. Jodian Pinkney

51 Nontuberculous Mycobacterial Disease Navigating the Labyrinth Dr. Rocio Hurtado

52 Q&A with Speakers Drs. Kathryn Hibbert, Benjamin Medof, Rocio Hurtado, Angela Frank, Rod Rahimi, and Jodian Pinkney

53 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fitin 2026 Dr. Rachel Rosovsky

54 Pulmonary Embolism An Update Dr. Alison Witkin

55 Pulmonary Hypertension Categorization and Evaluation Dr. Josanna Rodriguez-Lopez

56 Pulmonary Hypertension Management Dr. Alexandra Wong

57 Vasculitis and ANCA Dr. Rachel Knipe

58 Q & A with Speakers Drs. Alison Witkin, Josanna Rodriguez-Lopez, Alexandra Wong, Angela Frank, and Rachel Rosovsky

59 Obstructive Sleep Apnea Dr. James Mojica

60 Central Sleep Apnea 2026 Dr. James Mojica

61 Sleep Diagnostics Dr. Katherine Dudley

62 Noninvasive Ventilation Dr. Katherine Dudley

63 Q & A with Speakers Drs. James Mojica and Katherine Dudley